Clinical Trials in North Carolina

Showing 5061-5080 of 15,496 trials

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

NCT03087591

This phase I trial studies the side effects and best dose of APN401 in treating patients with pancreatic cancer, colorectal cancer, or other solid tumors that have spread to other places in the body or have come back. APN401 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Metastatic Malignant Neoplasm in the BrainMetastatic Solid NeoplasmRecurrent Colorectal Carcinoma+9 more

Wake Forest University Health Sciences11 participantsStarted Apr 2017

Winston-Salem, North Carolina, United States

COMPLETEDNA46 miles

Med-South Lifestyle Program Implementation Study

NCT05067816

The purpose of this study is to determine the processes by which a previously proven lifestyle intervention (the Med-South Lifestyle Program) can most effectively and efficiently be translated into public health and clinical practice to positively impact chronic disease risk reduction among mostly minority, rural, and medically underserved populations.

Healthy Lifestyle

University of North Carolina, Chapel Hill368 participantsStarted Oct 2021

Chapel Hill, North Carolina, United States

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

Med-South Lifestyle Program Implementation Study

Find Trials by Condition in North Carolina

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors

Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Wearable Assessments in the Clinic and Home in PD

REmodeling the Left Ventricle With Atrial Modulated Pacing

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)